• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生酮饮食治疗慢性肾脏病的潜力:药理学研究进展与治疗前景。

Potentials of ketogenic diet against chronic kidney diseases: pharmacological insights and therapeutic prospects.

机构信息

ABEx Bio-Research Center, East Azampur, Dhaka, 1230, Bangladesh.

Department of Pathology, Faculty of Veterinary, Animal and Biomedical Sciences, Sylhet Agricultural University, Sylhet, 3100, Bangladesh.

出版信息

Mol Biol Rep. 2022 Oct;49(10):9749-9758. doi: 10.1007/s11033-022-07460-8. Epub 2022 Apr 20.

DOI:10.1007/s11033-022-07460-8
PMID:35441940
Abstract

BACKGROUND

Chronic kidney disease (CKD) is a worldwide public health concern. Nutritional interventions become a primary concern in managing various diseases, including CKD. Ketogenic diets (KD) are a popular diet and an increasingly used diet for weight loss.

MAIN BODY

With the increasing cases of CKD, KD has been proposed as a treatment by many scientists. Several studies have shown that KD can slow down the progression rate of renal abnormalities. Also, this diet is regarded as a safe route for managing CKD. CKD is generally associated with increased inflammation, oxidative stress, fibrosis, autophagy dysfunction, and mitochondrial dysfunction, while all of these can be attenuated by KD. The protective effect of KD is mainly mediated through inhibition of ROS, NF-κB, and p62 signaling.

CONCLUSIONS

It is suggested that KD could be considered a new strategy for managing and treating CKD more carefully. This review explores the potential of KD on CKD and the mechanism involved in KD-mediated kidney protection.

摘要

背景

慢性肾脏病(CKD)是一个全球性的公共卫生关注点。营养干预措施成为管理各种疾病(包括 CKD)的首要关注点。生酮饮食(KD)是一种流行的饮食方式,也是越来越多用于减肥的饮食方式。

正文

随着 CKD 病例的增加,KD 已被许多科学家提出作为一种治疗方法。多项研究表明,KD 可以减缓肾脏异常的进展速度。此外,这种饮食被认为是管理 CKD 的一种安全途径。CKD 通常与炎症增加、氧化应激、纤维化、自噬功能障碍和线粒体功能障碍有关,而 KD 可以减轻所有这些问题。KD 的保护作用主要通过抑制 ROS、NF-κB 和 p62 信号来介导。

结论

建议更仔细地考虑 KD 作为管理和治疗 CKD 的一种新策略。本综述探讨了 KD 在 CKD 中的潜在作用以及 KD 介导的肾脏保护中涉及的机制。

相似文献

1
Potentials of ketogenic diet against chronic kidney diseases: pharmacological insights and therapeutic prospects.生酮饮食治疗慢性肾脏病的潜力:药理学研究进展与治疗前景。
Mol Biol Rep. 2022 Oct;49(10):9749-9758. doi: 10.1007/s11033-022-07460-8. Epub 2022 Apr 20.
2
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.生酮饮食可减轻急性和慢性缺血性肾损伤,并降低氧化应激和炎症标志物。
Life Sci. 2022 Jan 15;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16.
3
Ketogenic diet attenuates oxidative stress and inflammation after spinal cord injury by activating Nrf2 and suppressing the NF-κB signaling pathways.生酮饮食通过激活Nrf2和抑制NF-κB信号通路减轻脊髓损伤后的氧化应激和炎症反应。
Neurosci Lett. 2018 Sep 14;683:13-18. doi: 10.1016/j.neulet.2018.06.016. Epub 2018 Jun 9.
4
Inflammation and oxidative stress in epileptic children: from molecular mechanisms to clinical application of ketogenic diet.癫痫儿童的炎症和氧化应激:从分子机制到生酮饮食的临床应用。
Rev Neurosci. 2024 Feb 14;35(4):473-488. doi: 10.1515/revneuro-2023-0128. Print 2024 Jun 25.
5
Ketogenic diet aggravates hypertension via NF-κB-mediated endothelial dysfunction in spontaneously hypertensive rats.生酮饮食通过 NF-κB 介导的内皮功能障碍加重自发性高血压大鼠的高血压。
Life Sci. 2020 Oct 1;258:118124. doi: 10.1016/j.lfs.2020.118124. Epub 2020 Jul 21.
6
Ketogenic Diet Elicits Antitumor Properties through Inducing Oxidative Stress, Inhibiting MMP-9 Expression, and Rebalancing M1/M2 Tumor-Associated Macrophage Phenotype in a Mouse Model of Colon Cancer.生酮饮食通过诱导氧化应激、抑制 MMP-9 表达和重新平衡 M1/M2 肿瘤相关巨噬细胞表型在结肠癌小鼠模型中发挥抗肿瘤作用。
J Agric Food Chem. 2020 Oct 7;68(40):11182-11196. doi: 10.1021/acs.jafc.0c04041. Epub 2020 Aug 19.
7
Ketogenic diet in combination with voluntary exercise impacts markers of hepatic metabolism and oxidative stress in male and female Wistar rats.生酮饮食联合自愿运动对雄性和雌性 Wistar 大鼠肝脏代谢和氧化应激的标志物有影响。
Appl Physiol Nutr Metab. 2020 Jan;45(1):35-44. doi: 10.1139/apnm-2019-0042. Epub 2019 May 22.
8
Modulation of oxidative stress and mitochondrial function by the ketogenic diet.生酮饮食对氧化应激和线粒体功能的调节。
Epilepsy Res. 2012 Jul;100(3):295-303. doi: 10.1016/j.eplepsyres.2011.09.021. Epub 2011 Nov 9.
9
Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.Tempol,一种超氧化物歧化酶模拟药物,可改善慢性肾脏病小鼠的肾病进展。
Cell Physiol Biochem. 2015;36(6):2170-82. doi: 10.1159/000430183. Epub 2015 Jul 21.
10
Ketonuria and Seizure Control in the Medium Chain Triglyceride and Classic Ketogenic Diets.中链甘油三酯饮食和经典生酮饮食对酮尿症和癫痫发作的控制作用。
Can J Neurol Sci. 2022 May;49(3):433-436. doi: 10.1017/cjn.2021.122. Epub 2021 Jun 2.

引用本文的文献

1
Database Analysis of Application Areas and Global Trends in Ketogenic Diets from 2019 to 2024.2019年至2024年生酮饮食应用领域及全球趋势的数据库分析
Nutrients. 2025 Apr 27;17(9):1478. doi: 10.3390/nu17091478.
2
Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals "KetoNut-SINut"; and the Italian society of nephrology (SIN).非透析慢性肾脏病患者肥胖的营养评估和医学膳食治疗:内分泌学家、营养师和肾脏病学家实用指南。意大利内分泌学会(SIE)、俱乐部营养-激素和代谢工作组;意大利营养保健品学会(SINut)、酮饮食和营养保健品“KetoNut-SINut”俱乐部;以及意大利肾脏病学会(SIN)的共识声明。
J Endocrinol Invest. 2024 Dec;47(12):2889-2913. doi: 10.1007/s40618-024-02446-8. Epub 2024 Sep 18.

本文引用的文献

1
Mitochondrial Pathophysiology on Chronic Kidney Disease.慢性肾脏病的线粒体病理生理学。
Int J Mol Sci. 2022 Feb 4;23(3):1776. doi: 10.3390/ijms23031776.
2
Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks.生酮饮食与慢性病:权衡利弊
Front Nutr. 2021 Jul 16;8:702802. doi: 10.3389/fnut.2021.702802. eCollection 2021.
3
Erythropoietin Gene Therapy Delays Retinal Degeneration Resulting from Oxidative Stress in the Retinal Pigment Epithelium.促红细胞生成素基因疗法延缓视网膜色素上皮细胞氧化应激所致的视网膜变性。
3
Can a Low-Phosphate Diet for Chronic Kidney Disease Treat Cancer? An Interdisciplinary Literature Review.慢性肾病的低磷饮食能治疗癌症吗?一项跨学科文献综述。
Medicines (Basel). 2024 Jan 30;11(2):5. doi: 10.3390/medicines11020005.
4
Targeting immunometabolism during cardiorenal injury: roles of conventional and alternative macrophage metabolic fuels.针对心肾损伤中的免疫代谢:传统和替代性巨噬细胞代谢燃料的作用
Front Physiol. 2023 Apr 28;14:1139296. doi: 10.3389/fphys.2023.1139296. eCollection 2023.
Antioxidants (Basel). 2021 May 25;10(6):842. doi: 10.3390/antiox10060842.
4
Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis.生酮饮食对 T2DM 患者血糖控制、胰岛素抵抗和脂代谢的影响:系统评价和荟萃分析。
Nutr Diabetes. 2020 Nov 30;10(1):38. doi: 10.1038/s41387-020-00142-z.
5
Advantages and Disadvantages of the Ketogenic Diet: A Review Article.生酮饮食的利弊:一篇综述文章。
Cureus. 2020 Aug 10;12(8):e9639. doi: 10.7759/cureus.9639.
6
Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.酮症可改善多囊肾病中的肾囊肿生长。
Cell Metab. 2019 Dec 3;30(6):1007-1023.e5. doi: 10.1016/j.cmet.2019.09.012. Epub 2019 Oct 17.
7
A ketogenic diet for reducing obesity and maintaining capacity for physical activity: hype or hope?生酮饮食减肥并维持体力活动能力:炒作还是希望?
Curr Opin Clin Nutr Metab Care. 2019 Jul;22(4):314-319. doi: 10.1097/MCO.0000000000000572.
8
CKD Hotspots: Challenges and Areas of Opportunity.CKD 热点:挑战与机遇领域。
Semin Nephrol. 2019 May;39(3):308-314. doi: 10.1016/j.semnephrol.2019.02.009.
9
Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways.复方α-酮酸片通过抑制 NF-κB 和 MAPK 通路缓解慢性肾脏病进展。
J Transl Med. 2019 Apr 11;17(1):122. doi: 10.1186/s12967-019-1856-9.
10
Watch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism.关注你(自身)的饮食:调节代谢的自噬机制。
Cell Metab. 2019 Apr 2;29(4):803-826. doi: 10.1016/j.cmet.2019.03.003.